NCT01606566 2022-02-18
A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.
PCI Biotech AS
Phase 2 Terminated
PCI Biotech AS
Copenhagen University Hospital at Herlev
National Cancer Institute (NCI)
National Cancer Institute (NCI)